Cancer and SILICONE Implant: Understanding the Risk of Breast Implant-Associated Lymphoma

• November 11, 2025
• By Fernando Amato

BIA-ALCL: Understanding the Risk of Lymphoma Related to Breast Implants

“Breast implant-associated lymphoma is rare, but needs to be taken seriously.”

---

BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma) is associated with breast implants, especially textured ones, being a rare type of lymphoma. Although rare, it is a real condition recognized by medical entities such as the FDA (USA) and the Brazilian Society of Plastic Surgery. Awareness of this risk is fundamental for patients to make informed decisions.

🔍 Highlights

• ✅ BIA-ALCL is not breast cancer, but a T-cell lymphoma.
• ⚠️ It is mainly related to textured implants.
• 📆 Symptoms usually appear 7 to 10 years after surgery.
• 🧪 Early diagnosis and capsule removal are crucial.
• 💬 Discussion about the risk should occur before implant placement.

---

🧬 What Is BIA-ALCL?

BIA-ALCL is an anaplastic large cell lymphoma, a rare type of cancer that develops in the lymphatic system. It does not originate from breast tissue, but rather from the capsule the body forms around the silicone implant.

📊 What Is the Incidence of BIA-ALCL?

The risk is considered low, but documented. The chance of developing BIA-ALCL ranges from 1 in 2,200 to 1 in 86,000 women with textured implants, depending on the brand and type of implant surface.

On the other hand, smooth implants have an extremely low risk, with very few cases described in medical literature.

⚠️ Risk Factors

• Textured surface of the implant.
• Allergan (Biocell) brand implants had a higher association.
• Exposure time: risk increases after 7 to 10 years.
• Immunological factors and presence of bacterial biofilm may be involved.

Read more about silicone implants and mammoplasty.

🧪 How Is the Diagnosis Made?

BIA-ALCL usually manifests as late seroma (fluid accumulation) around the implant or the formation of a mass in the breast or armpit.

If the patient presents these signs, the doctor will request:

• Ultrasound or magnetic resonance imaging.
• Fluid aspiration for cytological analysis.
• In some cases, capsule biopsy.

🏥 Treatment and Prognosis

The treatment, however, consists of the complete removal of the capsule and the implant. When done early, the prognosis is excellent, with high cure rates.

It is fundamental to carry out follow-up with a plastic surgeon and, if necessary, with an oncologist.

Check out about adequate hospital structure and about anesthesia in plastic surgery.

📌 What Do Medical Authorities Say?

Both the FDA and the International Society for Aesthetic Plastic Surgery (ISAPS) recognize the risk and recommend that:

• Patients should receive communication about the risk of BIA-ALCL.
• The doctor should discuss the choice of implant type based on the patient's profile and history.
• Authorities should remove high-risk textured implants from the market, as happened with the Allergan Biocell line.

🧭 Should I Be Concerned?

There is no recommendation for preventive removal of implants in asymptomatic patients, but regular follow-up is essential.

Also read about pre-operative exams, preparation for surgery, and the risks of smoking.

👩‍⚕️ Conclusion

BIA-ALCL is a low, but real risk, and its main association is with textured implants, especially those from the Biocell line.

The doctor should choose the prosthesis with discretion, and patients with already placed implants should maintain regular medical follow-up, be informed about symptoms, and undergo examinations whenever there is suspicion.

Therefore, if you have doubts or unusual symptoms, schedule an appointment with your trusted plastic surgeon.

---

⭐ Final Highlights

• 🔬 BIA-ALCL is a lymphoma, not breast cancer.
• ⏳ Symptoms usually appear years after implant.
• 🧫 Textured implants are more commonly associated.
• 🔍 Diagnosis involves imaging and fluid analysis.
• 💡 Medical follow-up is your main safety.

---

❓ FAQ (schema.org/FAQPage)

1. What is BIA-ALCL?
It is a rare lymphoma associated with the capsule that forms around breast implants, mainly textured ones.

2. Is BIA-ALCL breast cancer?
No. It is a T-cell lymphoma, and does not originate from breast tissue.

3. What is the main cause of BIA-ALCL?
It is believed that chronic inflammation of the capsule, possibly associated with bacteria and genetic factors, is involved.

4. Do all types of implants cause BIA-ALCL?
No. Smooth implants have virtually no risk.

5. Should I remove my implant if it is textured?
Not necessarily. The recommendation is regular medical follow-up, without preventive removal in asymptomatic cases.

6. What are the symptoms of BIA-ALCL?
Swelling, late seroma, pain, or a lump in the breast/armpit years after the implant.

7. How is BIA-ALCL diagnosed?
By imaging exams and fluid analysis or capsule biopsy.

8. What is the treatment for BIA-ALCL?
Complete removal of the implant and the capsule around it.

9. Is the prognosis good?
Yes, especially when diagnosis is early and treatment is performed appropriately.

Share this article:

Related articles